Patients Blame H&N Therapy for Lasting Speech Issues

(MedPage Today) -- SCOTTSDALE, Ariz. -- Patients with oropharyngeal cancer reported significant voice and speech impairment for up to 2 years after chemoradiation therapy, but most of their doctors saw no evidence of it, data from a prospective study showed.
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news